secwatch / observer
8-K filed November 24, 2023, 6:59 PM ET CIK 0001401395
debt confidence high sentiment neutral materiality 0.50

Neptune Wellness Solutions Inc.: debt financing — Neptune subsidiary Biodroga enters $3M accounts receivable and inventory financing with Alterna Capital

Neptune Wellness Solutions Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Neptune Wellness Solutions Inc. incurred credit facility of $3 million with Alterna Capital Solutions LLC at prime plus 1% with a minimum interest rate of 9.5% per annum maturing initial twelve (12) month term, followed by automatic annual renewal terms.

Instrument
credit facility
Principal
$3 million
Counterparty
Alterna Capital Solutions LLC
Rate
prime plus 1% with a minimum interest rate of 9.5% per annum
Maturity
initial twelve (12) month term, followed by automatic annual renewal terms
Event
incurrence
Exact text from the filing
(the “Company”) executed an Invoice Purchase and Sale Agreement (the “PSA”) with Alterna Capital Solutions LLC (the “Lender”), dated November 8, 2023, providing for the purchase by the Lender of certain of Biodroga’s accounts receivable.
View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR
accession 0001437749-23-032991
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.